New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, demonstrated that polyarticular juvenile idiopathic arthritis patients were more likely ...
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has approved XELJANZ® (tofacitinib) for the treatment of active polyarticular juvenile idiopathic ...
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, found that patients started on early, aggressive treatment with a combination of biologic ...
Twenty-one patients with JRA (13 polyarticular arthritis, eight systemic arthritis) received etanercept (0.4 mg/kg/dose, maximum 25 mg/dose). The average age of onset of JRA in our population was ...
Children with arthritis affecting five or more joints, called polyarticular juvenile idiopathic arthritis (polyarticular JIA), living in less affluent families were twice as likely to report more than ...
WASHINGTON, Oct. 3, 2025 /PRNewswire/ -- There are new long-term results from a landmark study using the CARRA Registry that looks at when to start biologics in children diagnosed with Polyarticular ...
Slow Speed Resistance Exercise Training in Children with Polyarticular Juvenile Idiopathic Arthritis
Juvenile idiopathic arthritis (JIA) is an inflammatory autoimmune disease that can cause severe impairment and disability. Exercise is recommended to preserve joint mobility and function. Dr. Kevin ...
Please provide your email address to receive an email when new articles are posted on . Kevzara is approved for polyarticular JIA in patients weighing 63 kg or greater. The drug is an IL-6 inhibitor ...
Please provide your email address to receive an email when new articles are posted on . Three strategies aimed at starting patients with polyarticular juvenile idiopathic arthritis on different ...
Dosage in the pJIA patient population can be achieved by using the 200mg/1.14mL prefilled syringe. The Food and Drug Administration (FDA) has approved Kevzara ® (sarilumab), an interleukin-6 receptor ...
Please can you give a brief introduction to Polyarticular juvenile idiopathic arthritis (PJIA)? How common is PJIA? Polyarticular Juvenile Idiopathic Arthritis (PJIA) is a type of Juvenile Idiopathic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results